HYA Advisors’s Gilead Sciences GILD Stock Holding History

HYA Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$358K	Buy	5,791 +67	+1%	+$4.15K	0.14%	95
2022 Q1	$340K	Buy	5,724 +70	+1%	+$4.47K	0.12%	118
2021 Q4	$411K	Buy	5,654 +54	+1%	+$3.72K	0.15%	103
2021 Q3	$381K	Hold	5,600	–	–	0.15%	104
2021 Q2	$386K	Hold	5,600	–	–	0.16%	99
2021 Q1	$362K	Hold	5,600	–	–	0.17%	98
2020 Q4	$326K	Hold	5,600	–	–	0.17%	98
2020 Q3	$354K	Hold	5,600	–	–	0.21%	82
2020 Q2	$431K	Hold	5,600	–	–	0.28%	65
2020 Q1	$419K	Sell	5,600 -2,520	-31%	-$174K	0.35%	55
2019 Q4	$528K	Buy	+8,120	New	+$529K	0.34%	56

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HYA Advisors's GILD Position: Q2 2022 in Review

HYA Advisors increased its Gilead Sciences (GILD) stake by 1.2% in Q2 2022, buying an estimated $4.15K and bringing the position to 5,791 shares worth $358K. The position accounts for 0.14% of the portfolio, ranked #95.

HYA Advisors first reported a position in GILD in Q4 2019 and has held it in 11 quarters since. The position peaked at $528K in Q4 2019. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

HYA Advisors held 5,791 shares of Gilead Sciences worth $358K as of Q2 2022.
HYA Advisors bought 67 Gilead Sciences shares in Q2 2022, an estimated $4.15K.
Gilead Sciences made up 0.14% of HYA Advisors's portfolio in Q2 2022, its #95 holding.
HYA Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 11 quarters since.
HYA Advisors's Gilead Sciences position peaked at $528K in Q4 2019.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on HYA Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.